These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2897910

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Serum prolactin and antipsychotic responses to pimozide in schizophrenia.
    Siris SG, van Kammen DP, De Fraites EG.
    Psychopharmacol Bull; 1978 Jan; 14(1):11-4. PubMed ID: 625528
    [No Abstract] [Full Text] [Related]

  • 48. 50 kD prolactin binding protein in schizophrenics on neuroleptic medication.
    Walker AM, Peabody CA, Ho TW, Warner MD.
    J Psychiatry Neurosci; 1992 Jun; 17(2):61-7. PubMed ID: 1353370
    [Abstract] [Full Text] [Related]

  • 49. [The "the therapeutic window" of neuroleptic levels in the erythrocytes of schizophrenics (proceedings)].
    Yesavage JA.
    Ann Med Psychol (Paris); 1979 Jun; 137(3-4):251. PubMed ID: 40511
    [No Abstract] [Full Text] [Related]

  • 50. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA, Fang VS, Meltzer HY.
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [Abstract] [Full Text] [Related]

  • 51. The influence of neuroleptic drugs on prolactin secretion in children.
    Gualtieri CT, Rojahn J, Staye J.
    Dev Med Child Neurol; 1980 Aug; 22(4):515-8. PubMed ID: 6105985
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Assessment of drugs in schizophrenia. Basic trial design.
    Lader M.
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):375-9. PubMed ID: 9964
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report.
    Boczkowski JA, Zeichner A, DeSanto N.
    J Consult Clin Psychol; 1985 Oct; 53(5):666-71. PubMed ID: 2865281
    [No Abstract] [Full Text] [Related]

  • 58. [Current assessment of new/atypical neuroleptic agents].
    Möller HJ.
    Nervenarzt; 2000 May; 71(5):329-44. PubMed ID: 10846708
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Propranolol and prolactin.
    Nasrallah HA, Freed WJ, Rogol A, Wyatt RJ.
    Lancet; 1977 Dec 03; 2(8049):1175-6. PubMed ID: 73083
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.